The Ozempic label lists nausea, vomiting, diarrhea, abdominal pain, and constipation as common adverse reactions reported in Ozempic patients, but it does not include these adverse reactions in its Warnings and Precautions section, nor does it warn that these adverse reactions are symptoms of more severe conditions, including gastroparesis, the lawsuit notes
People taking these medicines often say theyre not as hungry and don't think about food as much
According to Evaluate, Lillys retatrutide (GLP-1/GIP/glucagon) hit 2324% in Phase 2, with 2030 sales modeled around $5.6B
By regulating appetite, improving blood sugar control, and promoting fat loss, these treatments offer more than cosmetic benefitsthey support long-term health improvements